{"id":"W1974903221","doi":"10.1056/nejmoa1311107","title":"Ceritinib in <i>ALK</i> -Rearranged Non–Small-Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1475,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Ceritinib; Crizotinib; Anaplastic lymphoma kinase; Medicine; ALK inhibitor; Internal medicine; Lung cancer; Oncology; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01245342306717361,"score_gpt":0.3153880680622122,"score_spread":0.3029346449950386,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}